Method of reducing cellular immune response involving T-cells us

Details Method of reducing cellular immune response involving T-cells us Method of reducing cellular immune response involving T-cells us

1991-04-25

1993-09-07

Nucker, Christine M.

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

424 88, 424 858, 424 93U, 514 2, 514 8, 514885, 530402, 530403, 530866, 530868, 4352523, A61K 7702, C07K 306

Patent

active

052426874

ABSTRACT:
Specific and nonspecific immunomodulation, enhancement of cellular engraftment, and modulation of nonimmune cells are achieved by using various membrane-binding and soluble CD8 compositions.

REFERENCES:
patent: 5071964 (1991-12-01), Dustin et al.
patent: 5116964 (1992-05-01), Capon et al.
Jiang, H. et al., Science 256:1213-1215, May 22, 1992, "Role of CD8+T Cells . . . ".
Koh, D. et al. Science 256:1210-1213, May 22, 1992, "Less mortality . . . ".
Medof, M. E. et al., J. Exp. Med. 160:1558-1578 (1984), "Inhibition of complement activation on the surface of cells after incorporation of Decay-accelerating factor."
Lenschow, D. J., et al., Science 257:789-792 (Aug. 7, 1992), "Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4-Ig."
Tan, P., et al., J. Exp. Med. 177:165-173 (Jan. 1993), "Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1".
Mueller, D. L., et al., Ann. Review Immunol. 7:445-480 (1989), "Clonal expansion versus functional clonal inactivation".
Norton, S. D., et al. J. Immunology 149:1556-1561 (Sep. 1992), "The CD28 ligand, B7, enhances IL-2 production by providing a costimulatory signal to T cells".
Rosenberg, A. S., Annu. Rev. Immunol. 1992 10:333-358, "Cellular basis of skin allograft rejection".
Wecker, H., et al. Curr. Opinion in Immunol. 1992 4:561-566, "Cellular mechanisms of rejection".
Cohen, J., Science 257:751 (Aug. 7, 1992), "Mounting a targeted strike on unwanted immune responses".
Auchincloss, H. Jr., et al., "Transplantation and Graft Rejection" in Fundamental Immunology, (W. F. Paul, ed.), 1989, Raven Press.
AIDS/HIV Experimental Treatment Directory, (Abrams, et al., ed.) vol. 2(2), pp. 100-101.
B. E. Bierer, et al. Ann. Review. Immunol. 1989, vol. 7:579-99. The Biological Roles of . . .
Y. Rosenstein, et al, J. Exp. Med. 169:149-160, Jan. 1989, Direct Evidence for Binding of CD8 . . .
P. J. Fink, Ann. Rev. Immunol. 6:115-137, 1988, "Veto Cells."
M. L. Tykocinski, et al., PNAS 85:3555-9, 1988, "Glycolipid reanchoring of T-lymphocyte . . . ".
M. A. J. Ferguson, Ann. Rev. Biochem., 57:285-320 "Cell Surface Anchorage of Proteins . . . ".
J. E. Hambour, et al. J. Exp. Med. Oct. 1988. vol. 168:1237-45, "Functional consequences of antisense . . .".
D. R. Kaplan, et al. PNAS 86:8512-15, Nov. 1989. "An immunoregulatory function for the CD8 molecule."
D. R. Littman, Ann. Rev. Immunology 5:561-84, 1987, "The structure of the CD4 and CD8 genes."
N. Fasel, et al. PNAS 86:6858-62, Sep. 1989, "In vitro attachment of glycohositolphospholipid . . . ".
D. R. Littman, et al. Cell 40:237-246, Feb. 1985, "The Isolation and Sequence of the Gene Encoding T8 . . . ".
Hambor et al., International Immunology 2(9):879, 1990.
Tomonari et al., International Immunology 2(12):1189, 1990.
Hambor et al., J. Immunology, 145:1646, 1990.
Miller, Immunology Today 7(4):112, 1986.
Vitiello et al., J. Imunology, 143:1512, 1989.
Scala et al., J. Immunology, 134(5):3049, 1985.
Norment et al., EMBO Journal, 7(10):3433, 1988.
Phillips et al., J. Exp. Med. 161:1464, 1985.
Kaplan et al., Proc. Natl. Acad. Sci. USA, 86:8512-15, 1988.
Furguson, Ann. Rev. Biochemistry, 57:285-295, 1988.
Claesson, Cellular Immunology 109:360-370, 1987.
Melchers et al., Scand. J. Immunol. 30:99-109, 1989.
Green et al., Ann. Rev. Immunol 1:43963, 1983.
Fink et al., J. Exp. Med. 157:141-154, 1983.
Kung et al., PCT WO 87/05912, Oct. 8, 1987, (T-Cell Sciences).
Rammensee, Intern. Rev. Immunol. 4:1754-191, 1989.

Affiliated with

Also associated with

Rating

Method of reducing cellular immune response involving T-cells us does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of reducing cellular immune response involving T-cells us, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of reducing cellular immune response involving T-cells us will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-486021